CVE-2026-21970

6.5 MEDIUM

📋 TL;DR

This vulnerability in Oracle Life Sciences Central Designer allows authenticated attackers with low privileges to access sensitive data via HTTP requests. It affects organizations using Oracle Health Sciences Applications version 7.0.1.0, potentially exposing critical healthcare research data.

💻 Affected Systems

Products:
  • Oracle Life Sciences Central Designer
Versions: 7.0.1.0
Operating Systems: Not specified - likely multiple
Default Config Vulnerable: ⚠️ Yes
Notes: Requires Oracle Health Sciences Applications component: Platform. Low privileged network access via HTTP is sufficient for exploitation.

📦 What is this software?

⚠️ Risk & Real-World Impact

🔴

Worst Case

Complete compromise of all accessible data in Oracle Life Sciences Central Designer, including sensitive clinical trial information, patient data, and proprietary research.

🟠

Likely Case

Unauthorized access to confidential research data, intellectual property theft, and potential regulatory compliance violations.

🟢

If Mitigated

Limited data exposure with proper network segmentation and access controls, though some sensitive information may still be accessible.

🌐 Internet-Facing: HIGH - Network accessible via HTTP with low privilege requirements makes internet-facing instances particularly vulnerable.
🏢 Internal Only: MEDIUM - Internal attackers with valid credentials can exploit this, but network segmentation reduces exposure.

🎯 Exploit Status

Public PoC: ✅ No
Weaponized: UNKNOWN
Unauthenticated Exploit: ✅ No
Complexity: LOW

Easily exploitable with low privileges via HTTP. No authentication bypass required.

🛠️ Fix & Mitigation

✅ Official Fix

Patch Version: Check Oracle Security Alert for specific patch version

Vendor Advisory: https://www.oracle.com/security-alerts/cpujan2026.html

Restart Required: Yes

Instructions:

1. Review Oracle Security Alert CPUJan2026 2. Download appropriate patch from Oracle Support 3. Apply patch following Oracle documentation 4. Restart affected services 5. Verify patch application

🔧 Temporary Workarounds

Network Segmentation

all

Restrict network access to Oracle Life Sciences Central Designer to only trusted IP addresses and networks

firewall-cmd --permanent --add-rich-rule='rule family="ipv4" source address="TRUSTED_IP" port protocol="tcp" port="80" accept'
netsh advfirewall firewall add rule name="Restrict Oracle LSCD" dir=in action=allow protocol=TCP localport=80 remoteip=TRUSTED_IP

Privilege Reduction

all

Implement least privilege access controls and review user permissions

🧯 If You Can't Patch

  • Implement strict network access controls and segment Oracle Life Sciences Central Designer from untrusted networks
  • Enable detailed logging and monitoring for unauthorized access attempts to sensitive data

🔍 How to Verify

Check if Vulnerable:

Check Oracle Life Sciences Central Designer version. If running 7.0.1.0, system is vulnerable.

Check Version:

Check Oracle application version through administrative interface or configuration files

Verify Fix Applied:

Verify patch application through Oracle patch management tools and confirm version is updated beyond 7.0.1.0

📡 Detection & Monitoring

Log Indicators:

  • Unusual data access patterns by low-privileged users
  • Multiple failed authentication attempts followed by successful low-privilege access
  • Access to sensitive data tables/files by unauthorized users

Network Indicators:

  • HTTP requests to sensitive endpoints from unexpected sources
  • Data exfiltration patterns from Oracle Life Sciences Central Designer

SIEM Query:

source="oracle_lscd" AND (event_type="data_access" AND user_privilege="low") AND data_sensitivity="high"

🔗 References

📤 Share & Export